Ignite Creation Date:
2024-05-06 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 2:28 PM
Study NCT ID:
NCT05292131
Status:
COMPLETED
Last Update Posted:
2023-12-22
First Post:
2022-03-14
Brief Title:
A Bioequivalence Study of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection Using an Autoinjector in Healthy Study Participants
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma